RITUXIMAB PLUS MULTIAGENT CHEMOTHERAPY FOR NEWLY DIAGNOSED CD20-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A PROSPECTIVE MULTICENTER PHASE II STUDY (RADICAL; KALLA0804) BY KOREAN ADULT ALL WORKING PARTY
EHA Library, Dae-Young Kim, 103400
EPIGALLOCATECHIN-3-GALLATE (EGCG) INDUCES APOPTOSIS IN CLL CELLS INVOLVING THE MODULATION OF PI3K/AKT PATHWAY AND INHIBITION OF PROTEASOME ACTIVITY
EHA Library, E. Ponath, 103395
EXPLORING THE ROLE OF KIT LIGAND AT THE ONSET OF HEMATOPOIESIS
EHA Library, Marella De Bruijn, 101364
POSSIBLE INTERPLAY OF MICRORNA AND TRANSCRIPTION FACTORS DURING IN VITRO ERYTHROID CULTURE OF CD34+ CELLS IN SICKLE CELL ANEMIA
EHA Library, Regiane Ferreira, 101363
AKT REGULATION OF ONCOGENIC NOTCH PATHWAY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Natalia Platonova, 101344
FAVORABLE OUTCOME OF PATIENTS WITH NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA HARBORING FLT3-ITD AND TREATED WITH CLADRIBINE ADDED TO DAUNORUBICIN AND CYTARABINE INDUCTION.
EHA Library, Wieslaw WIktor Jedrzejczak, 101345
OFATUMUMAB (O) IN COMBINATION WITH FLUDARABINE (F) AND CYCLOPHOSPHAMIDE (C) (OFC) VS. FC IN PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): RESULTS OF THE PHASE III STUDY COMPLEMENT 2
EHA Library, Tadeusz Robak, 101347
FINALLY A METHOD FOR ROUTINE DIAGNOSIS OF SOUTH-EAST ASIAN OVALOCYTOSIS
EHA Library, Pamela McLaughlin, 101348
EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE COMBINATION IN PATIENTS WITH POEMS SYNDROME PRE-TREATED OR INELIGIBLE FOR HIGH-DOSE THERAPY: RESULTS OF A PROSPECTIVE TRIAL.
EHA Library, Andrea Nozza, 101349
POST TRANSPLANT ERYTHROCYTOSIS IN ELEVEN CASES
EHA Library, Pinar Ataca, 101350
ANTIMICROBIAL-RESISTANT GRAM-NEGATIVE BACTERIA IN BLOODSTREAM INFECTIONS IN PATIENTS WITH PEDIATRIC HEMATOLOGY & ONCOLOGY AND PEDIATRIC BONE MARROW TRANSPLANTATION UNIT
EHA Library, Gulyuz Ozturk, 101351
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH HEMOPHAGOCYTIC SYNDROME: SINGLE CENTER EXPERIENCE
EHA Library, Gulyuz Ozturk, 101352
PERSIST-1: A PHASE III STUDY OF PACRITINIB (PAC) VS BEST AVAILABLE THERAPY (BAT) IN PRIMARY MYELOFIBROSIS (PMF), POST-POLYCYTHEMIA VERA MF (PPV-MF) OR POST-ESSENTIAL THROMBOCYTHEMIA MF (PET-MF)
EHA Library, Claire Harrison, 101353
PREVALENCE AND TRENDS OF HBV, HCV, AND HIV SEROLOGICAL AND NAT MARKERS AND PROFILES IN SAUDI BLOOD DONORS
EHA Library, Wafa Elbjeirami, 101354
THE TYK2 PATHWAY AS A NOVEL THERAPEUTIC INTERVENTION SITE IN AGGRESSIVE T-CELL LYMPHOMA
EHA Library, Nicole Prutsch, 101356
SEVERE NEONATAL JAUNDICE DUE TO A DE NOVO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENT CLASS I MUTATION
EHA Library, Rafael Del Orbe Barreto, 101357
A NOVEL HOTSPOT FOR IKZF1 WHOLE GENE DELETIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Mariana Emerenciano, 101358
EXPRESSION ANALYSIS OF GENES LOCATED IN THE COMMON REGION OF AMPLIFICATION IN PEDIATRIC B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH INTRACROMOSSOMAL AMPLIFICATION OF CHROMOSOME 21
EHA Library, Mariana Emerenciano, 101359
NQO1 C609T VARIANTS ARE ASSOCIATED WITH TYPE I AND II MUTATIONS IN PEDIATRIC ACUTE MYELOID LEUKEMIA
EHA Library, Francianne Gomes Andrade, 101360
ASSESSMENT OF THE EFFECTS OF ANEMIA ON CARDIOVASCULAR FINDINGS IN OBESE ADOLESCENTS
EHA Library, Hale Oren, 101361
PLASMA EXCHANGE FOR ACUTE HUMORAL REJECTION OF RENAL ALLOGRAFT AFTER ABO-MATCH KIDNEY TRANSPLANTATION: 5-YEAR EXPERIENCE IN A UNIVERSITY HOSPITAL.
EHA Library, Ingrid Parra Salinas, 101362
Combination of gene transfer and forced Chromatin looping concurrently to decreases Sickle Cell Hemoglobin and Reactivates the Synthesis of Fetal Hemoglobin in patient cells
EHA Library, Stefano Rivella, 103159
Analysis of new GFI1B variants in patiens with inherited bleeding and platelet disorders
EHA Library, Anna Marneth, 103130
DNMT3A R882 mutations promote chemoresistance and therapeutic relapse through impaired DNA damage sensing
EHA Library, Olga Guryanova, 103231
Recurrent MTORC1-activating RRAGC Mutations in Follicular Lymphoma
EHA Library, Jessica Okosun, 103072
Eloquent-2: A phase 3, randomized, open-label study of lenalidomide/dexamethasone with or without elotuzumab in patients with relapsed/refractory multiple myeloma
EHA Library, Meletios Dimopoulos, 103089
EHA20 José Carreras Award: Opening ceremony
EHA Library, David Grimwade, 103637
Curing APL through therapy induced PML/RARA degradation
EHA Library, Hugues de Thé, 103638
EHA20 Opening Ceremony: President's speech
EHA Library, Christine Chomienne, 103635
HIGH-DOSE CORTICOSTEROID ASSOCIATED WITH CATHETER-RELATED THROMBOSIS AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Xiaohui Zhang, 103104
HIF-2? IS A TUMOUR SUPPRESSOR IN AML
EHA Library, Milica Vukovic, 103055
ALLO-HSCT FOLLOWING RIC FOR ELDERLY PATIENTS (60 YEARS AND OLDER) WITH HEMATOLOGICAL MALIGNANCIES USING UNRELATED DONORS: A RETROSPECTIVE STUDY OF THE SFGM-TC.
EHA Library, Jean El Cheikh, 103149
UPDATED OVERALL SURVIVAL ANALYSIS OF THE FIRST STUDY: CONTINUOUS LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE VS MELPHALAN, PREDNISONE, AND THALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
EHA Library, Thierry Facon, 103068
HEALTH RESOURCE UTILIZATION WITH CONTINUOUS LENALIDOMIDE TREATMENT (TX) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
EHA Library, Katja Weisel, 103069
RAPID REVERSAL OF RED BLOOD CELL SICKLING PROMOTED BY PEGYLATED CARBOXYHEMOGLOBIN BOVINE GAS TRANSFER PROPERTIES
EHA Library, Ronald Jubin, 103216
CSNK1A1 BEHAVES LIKE A TUMOR SUPPRESSOR GENE AND MUTATIONS IN CSNK1A1 ASSOCIATE WITH MUTATIONS IN SPLICEOSOMAL GENES IN MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q)
EHA Library, Manja Meggendorfer, 103140
GENETIC PROFILE OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH ULTRA-STABLE DISEASE
EHA Library, Sara Raponi, 103138
BLINATUMOMAB SAFETY AND ACTIVITY IN OLDER PATIENTS WITH RELAPSED/REFRACTORY B?PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN TWO PHASE 2 STUDIES
EHA Library, H Kantarjian, 103113
INTERNATIONAL EXTRANODAL NK/T-CELL LYMPHOMA PROJECT: PROGNOSTIC FACTORS IN THE ERA OF NONANTHRACYCLINE-BASED TREATMENT
EHA Library, Seok Jin Kim, 103208
NEOD001 DEMONSTRATES CARDIAC AND RENAL BIOMARKER RESPONSES IN A PHASE 1/2 STUDY IN PATIENTS WITH AL AMYLOIDOSIS AND PERSISTENT ORGAN DYSFUNCTION
EHA Library, Michaela Liedtke, 103131
INOTUZUMAB OZOGAMICIN IN COMBINATION WITH LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) FOR THE FRONTLINE THERAPY IN ELDERLY PATIENTS (?60 YEARS) WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
EHA Library, Elias Jabbour, 103176
CLL SUSCEPTIBILITY SNPS IN MBL SIBLINGS OF CLL PATIENTS
EHA Library, Valeri Nteleah, 103234
SRSF2 P95H MUTATION RESULTS IN IMPAIRED STEM CELL REPOPULATION AND COMPROMISED HEMATOPOIETIC DIFFERENTIATION IN MICE
EHA Library, Ayana Kon, 103217
CONVERGENCE OF SOMATIC MUTATIONS WITHIN THE JAK-STAT SIGNALLING PATHWAY IN A NOVEL RUNX1-MUTATED PEDIGREE
EHA Library, Csaba Bödör, 103191
ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS OLDER THAN 60 YEARS: A SURVEY FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT.
EHA Library, Gabrielle Roth Guepin, 103083
THE SINGLE-UNIT BLOOD TRANSFUSION: EXPERIENCE AND IMPACT IN HAEMATOLOGY PATIENTS.
EHA Library, Allameddine Allameddine, 103211
PRESENCE OF JAK2V617F MUTATION IN ENDOTHELIAL CELLS FROM BUDD-CHIARI SYNDROME PATIENTS IS NOT CORRELATED WITH PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM.
EHA Library, Ricardo Helman, 103194
A DOSE-ESCALATION STUDY OF THE BCL-2 INHIBITOR VENETOCLAX (ABT-199/GDC-0199) PLUS BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON-HODGKIN?S LYMPHOMA (NHL)
EHA Library, Sven deVos, 103123
HOSPITAL VERSUS HOME CARE FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN CURATIVE OR TERMINAL PHASE: USE OF THE RESOURCES ANALYSIS, SYMPTOM BURDEN AND COST-EFFECTIVENESS STUDY
EHA Library, Alessandra Ferrajoli, 103112
LONG-TERM OUTCOME OF 490 PATIENTS WITH EARLY-STAGE EXTRA-NODAL MARGINAL ZONE LYMPHOMA
EHA Library, Joachim Yahalom, 103173
HIGH-THROUGHPUT T-CELL RECEPTOR GENE REPERTOIRE PROFILING IN CHRONIC LYMPHOCYTIC LEUKEMIA SUBSET #4: FURTHER EVIDENCE OF ANTIGENIC STIMULATION
EHA Library, Anna Vardi, 103209
UNRELATED DONOR (UD) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA (AML): REPORT OF 381 PATIENTS FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
EHA Library, Eolia Brissot, 103119
A RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY OF BORTEZOMIB AND DEXAMETHASONE WITH OR WITHOUT ELOTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Andrzej J. Jakubowiak, 103091
DEVELOPMENT OF A PREDICTIVE SCORE FOR THE IDENTIFICATION OF LYMPHOMA PATIENTS AT RISK FOR THROMBOEMBOLISM
EHA Library, Darko Antic, 103202
AN ONGOING MULTINATIONAL OBSERVATIONAL STUDY IN MULTIPLE MYELOMA (PREAMBLE): A PRELIMINARY REPORT OF DISEASE IMPACT ON QUALITY OF LIFE
EHA Library, David Cella, 103090
NILOTINIB IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH PHILADELPHIA- POSITIVE ALL: RESULTS OF THE EUROPEAN WORKING GROUP FOR ADULT ALL(EWALL-PH-02)
EHA Library, Heike Pfeifer, 103213
PHASE 1 MULTIPLE ASCENDING DOSE STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS/PHARMACODYNAMICS OF AG-348, A FIRST-IN-CLASS ALLOSTERIC ACTIVATOR OF PYRUVATE KINASE-R, IN HEALTHY SUBJECTS
EHA Library, Hua Yang, 103061
IN VIVO TREATMENT BY LENALIDOMIDE CHANGES THE CLONAL EVOLUTION OF HEMATOPOIETIC STEM PROGENITOR CELLS OF NON DEL(5Q) LOW RISK MDS PATIENTS.
EHA Library, Virginie Chesnais, 103181
THE ROLE OF 2-OXOGLUTARATE DEPENDENT DIOXYGENASES IN NORMAL HAEMATOPOIESIS AND ACUTE MYELOID LEUKEMIA
EHA Library, Catarina Sepulveda, 103160
EFFICACY AND SAFETY OF CD19-TARGETED 19-28Z CAR MODIFIED T CELLS IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-ALL
EHA Library, Jae H. Park, 103203
REDUCED INTENSITY CONDITIONING (RIC) ALLO TRANSPLANTATION IS ASSOCIATED WITH SUPERIOR LONG-TERM DISEASE CONTROL IN RELAPSED/REFRACTORY GRADE I/II (G-I/II) FOLLICULAR LYMPHOMA
EHA Library, Evgeny Klyuchnikov, 103111
IMPACT OF PRIOR TREATMENT ON PFS FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PATIENTS RANDOMIZED TO LENALIDOMIDE VS INVESTIGATOR?S CHOICE: A SUBGROUP ANALYSIS OF THE PHASE II MCL-002 (SPRINT) STUDY
EHA Library, Marek Trneny, 103096
OPTIMAL DURATION OF ANTICOAGULANT THERAPY FOR THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS
EHA Library, Chatree Chai-adisaksopha, 103094
INITIAL ANALYSIS OF THE PHENOTYPIC CONSEQUENCES OF SF3B1 K700E MUTATION EXPRESSION IN VITRO AND IN VIVO
EHA Library, Vijitha Sathiaseelan, 103120
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY
EHA Library, Paolo Sportoletti, 103088
INTERIM RESULTS FROM A PHASE 2A, OPEN-LABEL, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN ADULT PATIENTS (PTS) WITH BETA-THALASSEMIA
EHA Library, Maria Domenica Cappellini, 103081
IDENTIFICATION OF RUNX1/ETO TARGETS REQUIRED FOR LEUKAEMIC PROPAGATION
EHA Library, Natalia Martinez, 103186
SUBGROUP ANALYSIS BY PRIOR TREATMENT AMONG PATIENTS WITH RELAPSED OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN THE PANORAMA 1 STUDY OF PANOBINOSTAT OR PLACEBO PLUS BORTEZOMIB AND DEXAMETHASONE
EHA Library, Hermann Einsele, 103051
ACCURACY OF PHYSICIAN ASSESSMENT OF TREATMENT PREFERENCES AND HEALTH STATUS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES
EHA Library, Giovanni Caocci, 103103
CLONAL ARCHITECTURE AND EVOLUTION IN MYELODYSPLASTIC SYNDROMES
EHA Library, Leonie Kroeze, 103156
CLONAL ARCHITECTURE DEFINES DISTINCT MECHANISMS FOR ACCUMULATION OF GENOMIC OR CHROMOSOMAL LESIONS IN ACUTE MYELOID LEUKEMIA
EHA Library, Pierre Hirsch, 103184
OUTCOMES OF OLDER PATIENTS EXPERIENCING REDUCED INTENSITY CONDITIONING ALLOGRAFT: RESULTS OF THE NCRI AML16 TRIAL
EHA Library, Nigel Russell, 103185
DISSECTING RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC LEUKEMIA USING WHOLE-EXOME SEQUENCING: IMPACT OF RECURRENT RPS15 MUTATIONS ON P53 DYSREGULATION
EHA Library, Viktor Ljungström, 103153
LEVELS OF DISCORDANCE BETWEEN PATIENTS? AND PHYSICIANS? PERCEPTIONS OF PATIENTS? HEALTH-RELATED QUALITY OF LIFE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA ? A CROSS-CULTURAL PERSPECTIVE
EHA Library, Maria TeresaPetrucci, 103144
THE THROMBIN INHIBITOR DABIGATRAN IMPAIRS CANCER CELL GROWTH AND PROGRESSION
EHA Library, Fabrizio Vianello, 103106
LUSPATERCEPT (ACE-536) INCREASES HEMOGLOBIN AND DECREASES TRANSFUSION BURDEN AND LIVER IRON CONCENTRATION IN ADULTS WITH BETA-THALASSEMIA: PRELIMINARY RESULTS FROM A PHASE 2 STUDY
EHA Library, Antonio Piga, 103099
IMPROVED OVERALL SURVIVAL WITH AUTOLOGOUS TRANSPLANTATION VS CYCLOPHOSPHAMIDE-LENALIDOMIDE-DEXAMETHASONE IN NEWLY DIAGNOSED MYELOMA: A PHASE 3 TRIAL
EHA Library, Francesca Gay, 103085
HIGH DOSE SEQUENTIALCHEMOTHERAPY WITH RITUXIMAB AND ASCT AS FIRST LINE THERAPY IN ADULT MCL PATIENTS: CLINICAL AND MOLECULARRESPONSE OF THE MCL0208 TRIAL, A FIL STUDY.
EHA Library, Sergio Cortelazzo, 103079
CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS TARGETING CD19 INDUCE SUSTAINED REMISSIONS IN CHILDREN AND YOUNG ADULTS WITH RELAPSED/REFRACTORY ALL
EHA Library, Shannon Maude, 103074
What Do We Know About Leukemic Events In Myeloproliferative Neoplasms?
EHA Library, Jean-Jacques Kiladjian, 103602
Remaining issues in pediatric ALL
EHA Library, Andre Baruchel, 103566
Haploidentical transplants: state of the art
EHA Library, Ibrahim Yakoub-Agha, 103622
What did we learn from CALR mutations
EHA Library, Heinz Gisslinger, 103601
T Replete or T-Deplete: which is better?
EHA Library, Andrea Bacigalupo, 103621
Signaling alterations in MPNs
EHA Library, Stefan N. Constantinescu, 103600
How to select the best available HSC donor
EHA Library, Jean-Marie Tiercy, 103620
Novel oncogenetic pathways in ALL
EHA Library, Tariq Enver, 103564
New And Emerging Prognostic And Predictive Biomarkers In ALL
EHA Library, Anthony Moorman, 103565
THE ROLE OF NRARP IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATHOGENESIS AND CHEMOTHERAPY SENSITIVITY
EHA Library, Rita Fragoso, 99686
THE INHIBITION OF CHECKPOINT KINASE 1 INCREASES THE EFFECTIVENESS OF CONVENTIONAL CHEMOTHERAPY IN B-/T-ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Andrea Ghelli Luserna Di Rora, 99687
LEUKEMOGENICITY OF RCSD1-ABL1 OF PH-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA VARIES BETWEEN FUSION SITES
EHA Library, Hayato Tamai, 99688
TRD/TRA REARRANGEMENTS OCCUR INFREQUENTLY IN EARLY THYMIC PRECURSOR SUBTYPE OF T LYMPHOBLASTIC LEUKEMIA BY HIGH-THROUGHPUT SEQUENCING
EHA Library, Anna Sherwood, 99689
CHARACTERIZATION OF IMMUNOPHENOTYPING AND MOLECULAR PROFILE OF FLT3 MUTATIONS IN CHILDHOOD T-CELL LEUKEMIA.
EHA Library, Maria do Socorro Pombo-de-Oliveira, 99693
PROGNOSTIC VALUE OF DELETIONS AND PROMOTER METHYLATION OF CDKN2A AND CDKN2B IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Marcin Braun, 99690
IMPACT OF SMALL MOLECULE INHIBITORS OF SKP2 IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Sara Colomer-Lahiguera, 99694
MAJOR IMPACT OF AN EARLY CHECKPOINT FOR MINIMAL RESIDUAL DISEASE IN FLOW CYTOMETRY IN CHILDHOOD ALL: A BICENTRIC STUDY
EHA Library, Marion Eveillard, 99691
TARGETING THE P53–MDM2 INTERACTION BY THE SMALL-MOLECULE MDM2 ANTAGONIST NUTLIN-3A IN ADULT PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
EHA Library, Stefania Trino, 99692
THE LNCRNAS MEG3 AND LINC-PINT REGULATE THE EXPRESSION OF HMOX1 IN ALL, SHOWING A POTENTIAL AS A THERAPEUTIC TARGETS FOR THIS DISEASE
EHA Library, Felipe Prosper, 99685
CUSTOMIZED NEXT-GENERATION SEQUENCING PANEL FOR IMPROVED CLINICAL DIAGNOSTICS OF HIGH-RISK B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDHOOD
EHA Library, Udo zur Stadt, 99684
FISH-BASED SCREENING FOR TYROSINE KINASE-ACTIVATING FUSION GENES IN CHILDHOOD HIGH-RISK B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP-ALL)
EHA Library, Karin Nebral, 99683

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings